Merck Drug Gets FDA Approval as a First-Line Lung Cancer Treatment

According to Wall Street Journal Merck Drug gets FDA approval as a First-Line lung cancer treatment. Link is HERE.

Year to date Merck stock price out performed Dow Jones Industrial by 4.7 times.